{"name":"Akela Pharma, Inc.","slug":"akela-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fentanyl TAIFUN","genericName":"Fentanyl TAIFUN","slug":"fentanyl-taifun","indication":"Moderate to severe pain (specific indication pending phase 3 results)","status":"phase_3"}]}],"pipeline":[{"name":"Fentanyl TAIFUN","genericName":"Fentanyl TAIFUN","slug":"fentanyl-taifun","phase":"phase_3","mechanism":"Fentanyl TAIFUN is a transdermal or inhalation formulation of fentanyl, a potent synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.","indications":["Moderate to severe pain (specific indication pending phase 3 results)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPNzQ2NXlTM0lCSDgwZ3hxSDRKM1Q5dkhwZ0cwN2NkZm1NZExRb0R4MUlSMFRjTkl1NjJWZGJObmVDcXJIRnlGTDA2SEozci04STJOaTA5Z0cxN0tvbHJDRFc2Ql9zdDNwYXRZeE11MW40Z0R2T0hzQUpuZ2JmcV9XdkVYZEQ0cGt5Q2l4VXpWVC01dWFzSXNPRldzVk5EM0hfUnJCLUVSdw?oc=5","date":"2014-03-31","type":"pipeline","source":"Business in Vancouver","summary":"New York finance firm sues Akela Pharma after investing millions, suit says - Business in Vancouver","headline":"New York finance firm sues Akela Pharma after investing millions, suit says","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}